Literature DB >> 9540296

Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

C B Nourse1, K M Butler.   

Abstract

Paediatric HIV infection has become a major burden on families, communities and health services worldwide. The vast majority of children now acquire HIV as a result of mother to infant (vertical) transmission. Recent major advances have occurred following the greater understanding of the risk factors for perinatal transmission and the role of antiretroviral therapy in preventing transmission. Now that interruption of vertical transmission is possible, early identification of HIV-infected pregnant women is critical. As of June 1997, HIV infection has been diagnosed in 37 children under 15 yrs of age in the Republic of Ireland; 32 as a result of maternal to infant transmission. The exact timing of HIV transmission during pregnancy is unclear but it is estimated that 60-70 per cent of infants may be infected at the time of delivery with approximately 30 per cent infected earlier in gestation. Vertical transmission rates vary from 15-40 per cent in different global areas. Antenatal and perinatal zidovudine treatment can reduce this rate by 60-70 per cent. Risk factors for the vertical transmission of HIV-1 are multifactorial. These factors include maternal disease status, in particular maternal viral load, route of delivery, duration of membrane rupture, presence of obstetric complications and infant feeding practices. Definitive diagnosis of HIV infection in infancy has been difficult in the past. Direct viral detection methods now allow the reliable diagnosis of HIV infection in the first few months of life. The most effective intervention to reduce perinatal HIV infection will be the better identification of HIV positive pregnant women with the subsequent introduction of measures to interrupt vertical transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540296     DOI: 10.1007/BF02937550

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  66 in total

1.  High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins.

Authors:  J J Goedert; A M Duliège; C I Amos; S Felton; R J Biggar
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

2.  Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.

Authors:  M J Mayaux; E Dussaix; J Isopet; C Rekacewicz; L Mandelbrot; N Ciraru-Vigneron; M C Allemon; V Chambrin; C Katlama; J F Delfraissy; J Puel
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

3.  HIV in pregnant women and their offspring: evidence for late transmission.

Authors:  A Ehrnst; S Lindgren; M Dictor; B Johansson; A Sönnerborg; J Czajkowski; G Sundin; A B Bohlin
Journal:  Lancet       Date:  1991-07-27       Impact factor: 79.321

4.  Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study.

Authors:  M L Newell; D T Dunn; C S Peckham; A E Semprini; G Pardi
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

5.  Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.

Authors:  L M Frenkel; M K Cowles; D E Shapiro; A J Melvin; D H Watts; C McLellan; K Mohan; B Murante; S Burchett; Y J Bryson; M J O'Sullivan; C Mitchell; D Landers
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

6.  Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors.

Authors:  M E St Louis; M Kamenga; C Brown; A M Nelson; T Manzila; V Batter; F Behets; U Kabagabo; R W Ryder; M Oxtoby
Journal:  JAMA       Date:  1993-06-09       Impact factor: 56.272

7.  Detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in breast milk and colostrum of seropositive mothers.

Authors:  P Buranasin; M Kunakorn; B Petchclai; K Raksakait; N Wichukchinda; M Jirapinyo; P Thongcharoen
Journal:  J Med Assoc Thai       Date:  1993-01

8.  The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group.

Authors:  M Burgard; M J Mayaux; S Blanche; A Ferroni; M L Guihard-Moscato; M C Allemon; N Ciraru-Vigneron; G Firtion; C Floch; F Guillot
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Postnatal transmission of AIDS-associated retrovirus from mother to infant.

Authors:  J B Ziegler; D A Cooper; R O Johnson; J Gold
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.